| Aerosolizable lipid nanoparticles for pulmonary delivery of mRNA through design of experiments H Zhang, J Leal, MR Soto, HDC Smyth, D Ghosh Pharmaceutics 12 (11), 1042, 2020 | 119 | 2020 |
| PEGylated chitosan for nonviral aerosol and mucosal delivery of the CRISPR/Cas9 system in vitro H Zhang, TF Bahamondez-Canas, Y Zhang, J Leal, HDC Smyth Molecular pharmaceutics 15 (11), 4814-4826, 2018 | 76 | 2018 |
| Manufacturing and ambient stability of shelf freeze dried bacteriophage powder formulations Y Zhang, X Peng, H Zhang, AB Watts, D Ghosh International journal of pharmaceutics 542 (1-2), 1-7, 2018 | 66 | 2018 |
| CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells G Chang, H Zhang, J Wang, Y Zhang, H Xu, C Wang, H Zhang, L Ma, Q Li, ... Cancer cell international 13, 1-13, 2013 | 63 | 2013 |
| PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro TF Bahamondez-Canas, H Zhang, F Tewes, J Leal, HDC Smyth Molecular Pharmaceutics 15 (4), 1643-1652, 2018 | 48 | 2018 |
| CD44 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells’ metastasis via the regulation of ERK1/2 G Chang, J Wang, H Zhang, Y Zhang, C Wang, H Xu, Y Lin, L Ma, Q Li, ... British journal of cancer 110 (4), 916-927, 2014 | 47 | 2014 |
| Just how prevalent are peptide therapeutic products? A critical review Y Zhang, H Zhang, D Ghosh, RO Williams III International journal of pharmaceutics 587, 119491, 2020 | 40 | 2020 |
| Decreased intracellular pH induced by cariporide differentially contributes to human umbilical cord-derived mesenchymal stem cells differentiation W Gao, H Zhang, G Chang, Z Xie, H Wang, L Ma, Z Han, Q Li, T Pang Cellular Physiology and Biochemistry 33 (1), 185-194, 2014 | 39 | 2014 |
| SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1/2 signaling pathway H Xu, Y Li, L Chen, C Wang, Q Wang, H Zhang, Y Lin, Q Li, T Pang International journal of oncology 48 (2), 613-623, 2016 | 38 | 2016 |
| The stabilizing excipients in dry state therapeutic phage formulations Y Zhang, H Zhang, D Ghosh AAPS PharmSciTech 21, 1-14, 2020 | 36 | 2020 |
| Down-regulation of lipocalin 2 suppresses the growth of human lung adenocarcinoma through oxidative stress involving Nrf2/HO-1 signaling B Song, H Zhang, L Jiang, Y Chi, J Tian, W Du, B Yu, Z Han Acta biochimica et biophysica Sinica 47 (10), 805-814, 2015 | 32 | 2015 |
| Therapeutic effects of micheliolide on a murine model of rheumatoid arthritis H Xu, J Wang, C Wang, G Chang, Y Lin, H Zhang, H Zhang, Q Li, T Pang Molecular medicine reports 11 (1), 489-493, 2015 | 24 | 2015 |
| CIAPIN1 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells׳ metastasis through regulation of MMPs via ERK1/2 signaling pathway J Wang, H Xu, Q Wang, H Zhang, Y Lin, H Zhang, Q Li, T Pang Experimental Cell Research 333 (1), 60-72, 2015 | 17 | 2015 |
| Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying H Zhang, Y Zhang, RO Williams III, HDC Smyth International Journal of Pharmaceutics 605, 120831, 2021 | 15 | 2021 |
| Overview of the delivery technologies for inhalation aerosols DF Moraga-Espinoza, AD Brunaugh, S Ferrati, LA Heersema, MJ Herpin, ... Inhalation Aerosols, 123-143, 2019 | 6 | 2019 |
| CIAPIN1 targets Na+/H+ exchanger 1 to mediate K562 chronic myeloid leukemia cells’ differentiation via ERK1/2 signaling pathway J Wang, H Xu, H Zhang, Q Wang, C Wang, H Zhang, Y Lin, Y Ru, H Liang, ... Leukemia Research 38 (9), 1117-1125, 2014 | 4 | 2014 |
| Biologically Active Dry Powder Compositions and Method of Their Manufacture and Use HDC Smyth, H Zhang, Z Cui, J Wang, H Xu, Y Zhang, D Ghosh, J Leal, ... WO Patent WO 2021/216541 A1, 2021 | 1 | 2021 |
| Development of non-viral systems for pulmonary nucleic acid delivery and gene editing H Zhang | | 2022 |
| Lipid Nanoparticle (LNP) Delivery Systems and Uses Thereof HDC Smyth, H Zhang, D Ghosh, J Leal, M Soto, Williams, III Robert O. WO Patent WO 2021/216577 A1, 2021 | | 2021 |
| Methods and compositions related to chitosan-derived nanoparticle-mediated crispr/cas9 delivery HDC Smyth, H Zhang, S Ferrati US Patent US 2019/0321477 A1, 2019 | | 2019 |
Hugh SmythProfessor, Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of TexasVerified email at mail.utexas.edu